Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group
- PMID: 27367788
- PMCID: PMC4992416
- DOI: 10.1097/MPG.0000000000001178
Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group
Abstract
Objectives: Hepatic encephalopathy (HE) is challenging to identify in children with acute liver failure and was not a requirement for enrollment into the Pediatric Acute Liver Failure Study Group (PALFSG). The outcomes of PALFSG participants presenting with and without HE are presented.
Methods: PALFSG participants were classified based on daily assessment of HE during the first 7 days following study enrollment: group 1-never developed HE; group 2-no HE at enrollment with subsequent HE development; and group 3-HE at study enrollment. Clinical and biochemical parameters and outcomes of death, spontaneous recovery, or liver transplantation were compared between groups.
Results: Data from 769 PALFSG (54% boys; median age 4.2 years; range 0-17.9 years) participants were analyzed, with 277 in group 1 (36%), 83 in group 2 (11%), and 409 in group 3 (53%). Mortality occurred in 11% of all participants and was highest among group 3 participants who demonstrated persistent grade III-IV HE (55%) or showed progression of HE (26%). Eleven (4%) group 1 participants died within 21 days of enrollment. Spontaneous recovery was highest in group 1 (79%) and lowest in group 2 (25%; P < 0.001).
Conclusions: Mortality 21 days after enrollment was highest in participants enrolled with severe HE (grades III or IV) or demonstrating HE progression. Four percent of participants without recorded clinical HE in the 7 days after enrollment, however, died within 21 days. Improved assessment of neurological injury and pediatric acute liver failure prognostication schema are needed.
Figures
Similar articles
-
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).J Hepatol. 2014 Feb;60(2):275-81. doi: 10.1016/j.jhep.2013.10.004. Epub 2013 Oct 12. J Hepatol. 2014. PMID: 24128414
-
Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.Hepatology. 2013 Apr;57(4):1542-9. doi: 10.1002/hep.26001. Epub 2013 Feb 4. Hepatology. 2013. PMID: 22886633 Free PMC article. Clinical Trial.
-
Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation.J Pediatr Gastroenterol Nutr. 1997 Feb;24(2):128-34. doi: 10.1097/00005176-199702000-00004. J Pediatr Gastroenterol Nutr. 1997. PMID: 9106097
-
Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation.Liver Transpl. 2015 Mar;21(3):369-80. doi: 10.1002/lt.24037. Epub 2015 Feb 10. Liver Transpl. 2015. PMID: 25366362 Review.
-
Acute liver failure in children.Pediatr Emerg Care. 2007 Feb;23(2):129-35. doi: 10.1097/PEC.0b013e3180308f4b. Pediatr Emerg Care. 2007. PMID: 17351416 Review.
Cited by
-
Long-term outcomes of pediatric liver transplantation in acute liver failure vs end-stage chronic liver disease: A retrospective observational study.World J Transplant. 2023 Mar 18;13(3):96-106. doi: 10.5500/wjt.v13.i3.96. World J Transplant. 2023. PMID: 36968135 Free PMC article.
-
Liver Transplant Listing in Pediatric Acute Liver Failure: Practices and Participant Characteristics.Hepatology. 2018 Dec;68(6):2338-2347. doi: 10.1002/hep.30116. Epub 2018 Nov 1. Hepatology. 2018. PMID: 30070372 Free PMC article.
-
A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients.Clin Gastroenterol Hepatol. 2018 Nov;16(11):1801-1810.e3. doi: 10.1016/j.cgh.2018.04.050. Epub 2018 Apr 30. Clin Gastroenterol Hepatol. 2018. PMID: 29723692 Free PMC article.
-
Recent advances in understanding inherited deficiencies in immunity to infections.F1000Res. 2020 Apr 7;9:F1000 Faculty Rev-243. doi: 10.12688/f1000research.22036.1. eCollection 2020. F1000Res. 2020. PMID: 32308976 Free PMC article. Review.
-
Pediatric liver failure: we came, we saw, but have we conquered?F1000Res. 2017 Aug 22;6:1540. doi: 10.12688/f1000research.9623.1. eCollection 2017. F1000Res. 2017. PMID: 28928955 Free PMC article. Review.
References
-
- Bernal W, Wendon J. Acute liver failure. New England Journal of Medicine. 2013;369(26):2525–34. - PubMed
-
- Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure. The Lancet. 2010;376(9736):190–201. - PubMed
-
- Rivera-Penera T, Moreno J, Skaff C, et al. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. Journal of pediatric gastroenterology and nutrition. 1997;24(2):128–34. - PubMed
-
- Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transplantation. 2000;6(2):163–69. - PubMed
-
- Sturm E, Lexmond WS, Verkade HJ. Pediatric acute liver failure: variations in referral timing are associated with disease subtypes. European journal of pediatrics. 2014:1–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources